Reduced physical function significantly increases mortality risk of middle-aged people living with HIV

postato in: Senza categoria | 0

HIV infection is
associated with reduced physical performance, investigators report in the
online edition of AIDS. They also
found that people living with HIV who had reduced physical function had a
significant increase in their mortality risk.
The study population
comprised middle-aged HIV-positive and HIV-negative people in Baltimore, United States, who either currently inject drugs or

Safer injecting practices would be better promoted by focusing on pleasure and practical concerns – not the risk of infection

postato in: Senza categoria | 0

Harm reduction interventions often fail to engage people who
inject drugs because they over-emphasise infection and risk, Magdalena Harris
of the London School of Hygiene and Tropical Medicine told the recent HIT Hot
Topics conference in Liverpool. Her interviewees frequently adopted safer
injecting practices, but were more motivated by a desire to have a

Safer injecting practices would be better promoted by focusing on pleasure and practical concerns – not the risk of infection

postato in: Senza categoria | 0

Harm reduction interventions often fail to engage people who
inject drugs because they over-emphasise infection and risk, Magdalena Harris
of the London School of Hygiene and Tropical Medicine told the recent HIT Hot
Topics conference in Liverpool. Her interviewees frequently adopted safer
injecting practices, but were more motivated by a desire to have a

Sofosbuvir/ledipasvir with ribavirin cures most people with hepatitis C recurrence after liver transplantation

postato in: Senza categoria | 0

An interferon-free
regimen of sofosbuvir plus ledipasvir (Harvoni)
taken with ribavirin for 12 or 24 weeks led to sustained virological response
in nearly all HCV genotype 1patients
with fibrosis or less-advanced liver cirrhosis, researchers reported at the American
Association for the Study of Liver Diseases (AASLD) Liver Meeting last month in
Boston, United States. Response rates

Sofosbuvir + simeprevir shows good results for hepatitis C in real-world use

postato in: Senza categoria | 0

Regimens containing sofosbuvir
(Sovaldi) – including sofosbuvir plus
simeprevir (Olysio) – work well for people
with hepatitis C genotype 1 in real-world use, which to date has included some
of the patients most urgently in need of treatment at the dawn of the
interferon-free era, according to a pair of presentations at the American
Association for

1 13 14 15 16 17 18 19 22